When I am reborn, I just want to be a top student

Galaxy Technology R&D Center.

Wang Donglai came here after the high-level meeting.

The reason is very simple, because good news came from the biological research laboratory of the R&D center.

In China, the funds invested by Galaxy Technology in scientific research are only lower than those of the Chrysanthemum Factory.

This low level is only because the scale of Galaxy Technology's development is still small and its cash flow is not as abundant as that of Chrysanthemum Factory.

However, if we compare them in terms of R&D areas, we can see that Galaxy Technology is much larger than Chrysanthemum Factory.

Just like biomedical research and development.

This is definitely a money-eating beast. Even if you invest hundreds of millions, tens of billions, or even millions of dollars, it may not produce any results.

Not to mention, building a laboratory from scratch requires a huge financial pressure just from the initial investment in equipment.

But Wang Donglai set it up like this.

At the beginning, whether it was people inside the group company or outsiders, after hearing the news, their first reaction was that Wang Donglai was a little too proud.

This concept continued until the emergence of Evergreen Liquid.

Although Changqing Liquid appears on the market as a shampoo, everyone understands that this is simply a choice made by Galaxy Technology in order to circumvent the drug review and listing approval process.

Moreover, from a business perspective, as a shampoo, the profit is far greater than that as a medicine.

Thanks to this product, Galaxy Technology's biomedicine research and development department has also become a popular department.

Just like before, after becoming famous, employees of this department of Galaxy Technology were wooed by outside companies.

From monthly salary to annual salary, and there are also shares and division of labor and so on.

It can be said that the salary is fully paid.

But, unfortunately, such means did not have any effect.

The reason is quite simple.

The product Changqing Liquid was not developed by Galaxy Technology’s biopharmaceutical research and development department at all.

It cannot be said that they did not do any work at all, it’s just that they were not clear about the most core work, technology and principles.

Even the craftsmanship is limited to a very small range.

Many places where leaks are involved adopt a human-contact approach to work.

In addition, since its rise, Galaxy Technology has never been short of poaching people.

Those R&D personnel who were dazzled by the external treatment became dizzy in the face of high salaries and forgot their true level.

As a result, when I went out, I was taught by reality how to be a human being.

As more and more such incidents occurred, the R&D personnel within Galaxy Technology naturally reached a general consensus.

If you don't master the real core technology within the R&D department of Galaxy Technology, it's better not to leave.

Even if you have mastered the key technology, staying in Galaxy Technology is a good choice.

Over time, there are fewer and fewer R&D personnel willing to change jobs.

Since its establishment, Wang Donglai has placed Galaxy Technology's R&D center at a very high level.

From R&D funds to R&D projects, a high degree of freedom and support are given.

Just like the biomedical research and development department, there are many project teams divided under it.

Some are developing new drugs, some are conducting genetic tracing, and some are developing international high-end projects.

If these R&D projects were carried out in other companies, they would probably be cut if no results were produced in a short period of time.

Even these project teams will not even be established.

To be honest, many domestic biomedical research and development companies have very little research and development funding.

There are even fewer projects to develop new drugs, and the work we are most willing to do is to conduct reverse analysis on some foreign drugs whose patents have expired, and then change their appearance and turn them into our domestically produced generic drugs.

We have caught up with Western developed countries in many areas, but in the field of biomedicine, we still lag far behind.

The gap in this area can only be caught up little by little.

Many medicines require huge amounts of money and time to be tested bit by bit.

There is almost no possibility of overtaking on a curve.

however.

With the development of technology, this thing that was originally thought to be impossible has shown a glimmer of hope.

That is artificial intelligence technology and quantum computer technology.

The powerful computing power can be fully used to conduct component simulation experiments.

All we need is sufficient data, which is not a problem for China.

The artificial intelligence medical assisted diagnosis system launched by Galaxy Technology is an attempt.

After gaining a reputation in the early stages, Wang Donglai later issued an order that no money should be made from this project.

We need to reduce costs in exchange for the cooperation of hospitals.

In some places, this cooperation is difficult to promote.

But in Qin Province, it's very simple.

With the data from these hospitals, the biomedical research and development department of Galaxy Technology has been busy figuring out how to apply this database.

In addition, with the guidance of Wang Donglai, some results were finally achieved.

"What do you think of the smart medical operating room project?"

In the office, Wang Donglai asked Chen Lingyue beside him.

"Chairman, this project is too difficult. The first problem to be solved is nanorobots, and the second is to solve the technical problems in medical treatment."

"If we want to make a fully intelligent medical operating room and achieve a lossless effect, the size of the nanorobot must be small, which requires a breakthrough in materials science."

"What's relevant is artificial intelligence technology, communication control technology, and overall system control."

“I think this project is more appropriate as a long-term goal.”

"Compared to this, I think the 'Bian Que' system we developed is more valuable, at least in this period."

"As technology develops, the application of artificial intelligence in the medical field will no longer be limited to auxiliary diagnosis or imaging."

"Our team has communicated with people in the medical field many times, and has also conducted on-site reference and learning for a period of time."

"Our country's population is just too large. Even though medical care has been expanding, it can't be done to a very good level."

"As the provincial capital, Tangdu has extremely scarce beds in some of the top three hospitals, so there is always a steady stream of patients coming to Tangdu for medical treatment."

“This is an overall problem, so I won’t go into details here.”

"What we can do, in my opinion, is to make good use of artificial intelligence technology."

"After observation and research, I found that the most time-consuming work for a doctor is paperwork."

“For example, input the condition and generate a pathology draft.”

"Also, many patients are like headless flies in the hospital. They can't find the clinic, don't know how to register, don't know how to pay, etc."

"We can solve these problems through artificial intelligence technology." "Doctors can just focus on seeing patients, and nurses can just assist them."

"Some tasks that are not related to medical care can be handed over to artificial intelligence technology. This will improve the efficiency of patients' medical treatment and the efficiency of hospitals' medical treatment, achieving a win-win effect."

"Of course, since it is named the 'Bian Que' system, artificial intelligence technology naturally has other uses in the medical field."

"For example, in clinical decision-making, medical AI can serve as the doctor's 'second brain'. We previously used auxiliary diagnosis algorithms to allow the algorithms to find problems in CT results and save doctors' time."

"Then, we can further optimize the algorithm to discover more lesions, and find out some extremely small lesions, such as early cancer screening and acute stroke detection, which will have considerable advantages."

“If computing power and algorithms are further developed, it can even help doctors make secondary diagnoses.”

"Using artificial intelligence's ability to mine big data, we can produce a comprehensive research report on the patient, combining the patient's medical history, genetic information, test results, etc., and finally output a general treatment recommendation."

"Of course, we have considered the problem."

“The advice given by intelligent AI is only an aid, not the final result.”

"We can use the previous example of intelligent medical auxiliary diagnosis system to test simulation performance in some low-risk scenarios, such as medical record organization, appointment registration and patient guidance."

"..."

Wang Donglai listened quietly to Chen Lingyue's report.

He was actually quite satisfied with what Chen Lingyue said.

However, it didn't show on his face.

After Chen Lingyue finished speaking, Wang Donglai spoke up: "You have been talking about this 'Bian Que' system for a long time. I have heard its advantages and its disadvantages."

"But I noticed that you didn't say when this system would be online. What's the reason?"

Chen Lingyue smiled awkwardly and said, "Chairman, the requirements of the Bian Que system are too high. We have tried it many times internally and asked engineers from within the company to help build the system program, but the results have not been satisfactory."

"So, I thought..."

When it came to this, Wang Donglai naturally understood.

Looking at Chen Lingyue who was looking at him eagerly, he said, "Okay, I understand what you mean."

"However, I need to first see what this technological breakthrough is that you have kept secret until now."

"If it's really that valuable, let alone writing the program, we can discuss other things."

"But if not, don't blame me."

Upon hearing this, Chen Lingyue slapped his chest hard.

"Chairman, don't worry, I will definitely satisfy you!"

"It seems our researchers have made a breakthrough in treating cancer tumors."

"But I don't know much about the specific technologies involved."

"It is precisely because the matter is of great importance that I notified you immediately."

Wang Donglai stood up immediately.

"what?"

“Cancer tumor?”

Wang Donglai was truly shocked.

If what Chen Lingyue said was true, it would be a huge earthquake for the whole world.

Seeing Wang Donglai’s dramatic reaction, Chen Lingyue also panicked.

"Chairman, it's not that exaggerated, it's not that exaggerated!"

"It's just a discovery of a type of cell that may be effective in treating cancer tumors. It's just a guess and has not been verified."

"It's just because it's a serious matter, so the project team reported it to me. I don't dare to make a decision, so I'm notifying you."

After listening to Chen Lingyue's detailed explanation, Wang Donglai finally understood everything.

His eyebrows furrowed fiercely, and he looked at Chen Lingyue and said, "Don't breathe so hard next time."

"I thought it was a real technological breakthrough."

Sitting down again, Wang Donglai began to ask for specific information.

"What exactly is going on?"

Chen Lingyue no longer dared to play smart, and immediately said: "One of the researchers below is called Xia Ping. He claims that he has mastered the technology of induced pluripotent stem cells."

"This so-called multipotent stem cell can undergo reverse differentiation and culture into cells with other functions."

"After Xia Ping completed the technical breakthrough, he immediately reported the situation and claimed that he would not release the technology until he met with the chairman."

"I have also communicated with Xia Ping. He said that he could give the technology to the company, but the company must give him a huge reward."

"Otherwise, he would never have come up with this technique."

Wang Donglai nodded, his eyes somewhat deep.

In fact, when he heard Chen Lingyue mention the induced pluripotent stem cell technology, he already had a rough idea of ​​it.

"Haven't you ever consulted relevant professionals?" Wang Donglai asked.

Chen Lingyue immediately replied: "In order to keep it confidential, I did not tell anyone about this matter. I just asked some researchers at the R&D center and got a general idea of ​​this induced pluripotent stem cell technology."

"Okay, I'm already at the R&D center, where's Xia Ping? Why hasn't he come yet?"

Wang Donglai asked with a hint of smile on his face.

"After this incident happened, I made special arrangements for Xia Ping to prevent the news from leaking out and being known by other companies."

"When you came, Chairman, I had someone bring him here. He should be here soon."

After Chen Lingyue finished speaking, he also noticed something was wrong.

I had sent someone to bring Xia Ping here long before Wang Donglai arrived.

As a result, I have been chatting with Wang Donglai for such a long time, but he still hasn't come over.

This time has obviously exceeded the limit.

I couldn't help but have a bad feeling in my heart.

After asking this question, Wang Donglai stopped asking and started asking other questions.

"Tell me about this biological research and development project team."

"No, you should tell me more about the R&D center, including the R&D personnel and the R&D projects they are working on."

"I think this is not a problem for you, right?"

After Wang Donglai finished speaking, he looked at Chen Lingyue, waiting for his answer.

Chen Lingyue clearly felt a sense of oppression from Wang Donglai's calm eyes.

Originally, the ominous premonition in my heart reappeared and became even stronger.

"Is there something wrong with this matter?"

This thought came to his mind, but Chen Lingyue did not show it on the surface. (End of this chapter)